Godavari Biorefineries Limited (GBL) reported a 12% year-on-year revenue growth in Q3 FY25, with revenue from operations increasing to Rs. 447.3 crore from Rs. 398 crore in Q3 FY24. The company’s EBITDA and Profit After Tax (PAT) also showed significant growth. GBL has been diversifying its revenue streams by focusing on bio-based chemicals and strengthening its ethanol division. The company has been expanding its capacity, licensing new technologies, and investing in new projects to reduce debt and optimize financial efficiency.
GBL’s Chairman, Samir Somaiya, emphasized the company’s commitment to building a sustainable, innovation-led bio-refining business. He highlighted the company’s efforts to reduce debt, increase efficiency, and drive long-term growth. The company has also benefited from the Indian government’s decision to allow the export of one million tons of sugar, which has improved sugar prices and helped the industry. Overall, GBL’s strong financial performance and strategic initiatives position the company for future growth and success.